Ovid Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| LEVIN JEREMY M | CEO | C | 71,000 | — | — | 3,687,715 | Dec 15, 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | — | C | 1,250,000 | — | — | 7,000,000 | Dec 8, 2025 |
| ALEXANDER MARGARET A. | President and COO | Sale | 5,279 | $0.56 | $2,956 | 73,406 | Feb 26, 2025 |
| Rona Jeffrey A | CBFO | Sale | 3,902 | $0.56 | $2,185 | 67,973 | Feb 26, 2025 |
| Rona Jeffrey A | CBFO | Award / Grant | 43,750 | — | — | 71,875 | Feb 20, 2025 |
| ALEXANDER MARGARET A. | President and COO | Award / Grant | 43,750 | — | — | 78,685 | Feb 20, 2025 |
| ALEXANDER MARGARET A. | President and COO | Purchase | 6,810 | $0.73 | $4,971 | 34,935 | Jan 27, 2025 |
| LEVIN JEREMY M | CEO | Purchase | 18,248 | $2.76 | $50,364 | 3,616,715 | Mar 18, 2024 |
| Tardio Jason | Chief Operating Officer | Award / Grant | 28,125 | — | — | 28,125 | Feb 22, 2024 |
| Rona Jeffrey A | CBFO | Award / Grant | 28,125 | — | — | 28,125 | Feb 22, 2024 |
| Perone Thomas Michael | General Counsel, Secretary | Award / Grant | 28,125 | — | — | 28,125 | Feb 22, 2024 |
| LEVIN JEREMY M | CEO | Gift | 573,275 | — | — | 4,171,742 | Dec 4, 2023 |
| Tardio Jason | Chief Operating Officer | Sale | 17,344 | $2.15 | $37,290 | — | Sep 12, 2022 |
| TAKEDA PHARMACEUTICAL CO LTD | — | Other | 5,750,000 | — | — | 5,750,000 | Jul 1, 2022 |
| Rakhit Amit | President and CMO | Sale | 34,017 | $3.71 | $126,203 | 726,823 | Jul 14, 2021 |
| LEVIN JEREMY M | CEO | Purchase | 8,488 | $5.84 | $49,570 | 5,792,530 | Aug 28, 2020 |
| LEVIN JEREMY M | CEO | Purchase | 60,000 | $2.50 | $150,000 | 4,736,529 | Oct 8, 2019 |
| TAKEDA PHARMACEUTICAL CO LTD | — | Purchase | 2,000,000 | $2.50 | $5,000,000 | 5,750,000 | Oct 8, 2019 |
| LEVIN JEREMY M | CEO | Gift | 465,116 | — | — | — | Sep 20, 2019 |
| Bernstein Karen | — | Purchase | 10,000 | $2.02 | $20,200 | 20,000 | Feb 26, 2019 |
| LEVIN JEREMY M | CEO | Purchase | 75,000 | $2.00 | $150,000 | 4,676,529 | Feb 22, 2019 |
| WILLIAMS DOUGLAS E | — | Purchase | 5,000 | $6.49 | $32,450 | 5,000 | Aug 14, 2018 |
| Bernstein Karen | — | Purchase | 10,000 | $6.23 | $62,300 | 10,000 | Aug 14, 2018 |
| LEVIN JEREMY M | CEO | Purchase | 15,334 | $7.15 | $109,638 | 4,601,529 | Aug 25, 2017 |
| During Matthew | President and CSO | C | 28,245 | — | — | 4,307,314 | May 10, 2017 |
| LEVIN JEREMY M | CEO | C | 35,461 | — | — | 35,461 | May 10, 2017 |